- ‘Silent’ COVID-19 Produces as Much Virus as in Patients With Symptoms: Study
- Immune System Clues to Why COVID Is Easier on Kids
- Is Shock Therapy Making a Comeback Against Bipolar Disorder?
- Conspiracy Theories Are Helping Fuel Rejection of Masks, Vaccines
- U.S. Coronavirus Cases Top 7 Million
- Health Highlights: Sept. 25, 2020
- After COVID-19 Exposure, When Can Young Athletes Resume Play?
- Kids Who Need Steroids Face Risk of Diabetes, Other Ills
- COVID Bites: Cracked Teeth Another Coronavirus Scourge
- Americans Are Cutting Back on Sugary Drinks
Clinical Trials Update: July 1, 2010
Here are the latest clinical trials, courtesy of ClinicalConnection.com:
High Cholesterol
This study seeks people aged 18 to 70 who take 40 mg. of Lipitor for high cholesterol. Qualified participants may be compensated up to $2,700.
The research site is in Phoenix, Ariz.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/high_cholesterol.aspx.
—–
Attention Deficit Hyperactivity Disorder (ADHD)
This study is for people with attention deficit hyperactivity disorder. You may qualify if you have trouble getting organized, paying attention or finishing tasks.
The research site is in Seattle, Wash.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/adhd.aspx.
—–
Iron-Deficiency Anemia
This study evaluating an intravenous iron medication seeks people with iron deficiency anemia and a history of unsatisfactory oral iron therapy.
The research site is in Atlanta, Ga.
More information
Please see http://www.clinicalconnection.com/clinical_trials/condition/anemia.aspx.
—–
Copyright 2010 ClinicalConnection.com. All rights reserved.
Source: HealthDay
